说说你对这篇新闻的看_老虎社区_美港股上老虎

说说你对这篇新闻的看法...

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":273778850001024,"tweetId":"273778850001024","gmtCreate":1707878355143,"gmtModify":1707878550534,"author":{"id":4098062154319340,"idStr":"4098062154319340","authorId":4098062154319340,"authorIdStr":"4098062154319340","name":"wenson6511","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>说说你对这篇新闻的看法...</p></body></html>","htmlText":"<html><head></head><body><p>说说你对这篇新闻的看法...</p></body></html>","text":"说说你对这篇新闻的看法...","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/273778850001024","repostId":2411317328,"repostType":2,"repost":{"id":"2411317328","kind":"highlight","pubTimestamp":1707871056,"share":"https://www.laohu8.com/m/news/2411317328?lang=&edition=full","pubTime":"2024-02-14 08:37","market":"us","language":"zh","title":"药明康德及药明生物再澄清，称不会对美国构成国家安全风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2411317328","media":"香港01","summary":"药明系再次发出澄清公告。药明康德（2359）重申没有人类基因组学业务，现有各类业务不会收集人类基因组数据。同时指出提供基于合同的研究、开发和","content":"<html><body><article><div></div><p><span>药明系再次发出澄清公告。<a href=\"https://laohu8.com/S/603259\">药明康德</a>（2359）重申没有人类基因组学业务，现有各类业务不会收集人类基因组数据。同时指出提供基于合同的研究、开发和生产服务，通过赋能全球制药和生命科学行业，致力于推动新药研发并为患者带来挽救生命的新药。</span></p><p>公司亦指出注意到，有美国议员于2024年2月12日致函美国商务部、财政部和国防部，其内容有关本公司。公司表示一向欢迎监管机构对行业监管，过去亦多次成功通过美国政府的审查。但是强烈反对针对公司的误导性指称、不确实认定和未经正当程序的预判行动。公司坚信在过去没有、现在和未来都不会对美国构成国家安全风险，即便美国政府再次对公司进行审查亦将得出相同结论。事实上，<a href=\"https://laohu8.com/S/02359\">药明康德</a>是全球制药和生命科学行业的重要贡献者之一。</p><div></div><div><div></div></div><div><div><div></div></div></div><div></div><h3><strong><a href=\"https://laohu8.com/S/02269\">药明生物</a>强调自己属独立公司</strong></h3><p>至于同系的药明生物（2269）亦发出公告，指出注意到有美国”议员于2月12日致函美国部分政府部门，其中提到公司。公司澄清并非药明康德新药，信函中的相关陈述失实，又强调公司是一家在香港联合交易所有限公司主板上市的独立公众公司，并独立运营其业务。</p><p>药明生物指出完全支持监管机构对行业监管，但强烈反对任何在未经正当考虑事实的情况下针该公司的不正确的陈述和缺乏根据的指控。公司谨此重申其过去没有、现在或未来也不会对美国或其他国家的国家安全构成风险，始终并将一贯遵守合规经营的原则，并遵照开展业务地区适用的法律法规运营。公司将一如既往地致力为全球医疗健康服务并作出贡献。</p><div></div><div><div></div></div><div></div><div></div><div></div></article></body></html>","source":"hk01_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>药明康德及药明生物再澄清，称不会对美国构成国家安全风险</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n药明康德及药明生物再澄清，称不会对美国构成国家安全风险\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-14 08:37 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.hk01.com/%E8%B2%A1%E7%B6%93%E5%BF%AB%E8%A8%8A/990624/%E8%97%A5%E6%98%8E%E5%BA%B7%E5%BE%B7%E5%8F%8A%E8%97%A5%E6%98%8E%E7%94%9F%E7%89%A9%E5%86%8D%E6%BE%84%E6%B8%85-%E7%A8%B1%E4%B8%8D%E6%9C%83%E5%B0%8D%E7%BE%8E%E5%9C%8B%E6%A7%8B%E6%88%90%E5%9C%8B%E5%AE%B6%E5%AE%89%E5%85%A8%E9%A2%A8%E9%9A%AA><strong>香港01</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>药明系再次发出澄清公告。药明康德（2359）重申没有人类基因组学业务，现有各类业务不会收集人类基因组数据。同时指出提供基于合同的研究、开发和生产服务，通过赋能全球制药和生命科学行业，致力于推动新药研发并为患者带来挽救生命的新药。公司亦指出注意到，有美国议员于2024年2月12日致函美国商务部、财政部和国防部，其内容有关本公司。公司表示一向欢迎监管机构对行业监管，过去亦多次成功通过美国政府的审查。...</p>\n\n<a href=\"https://www.hk01.com/%E8%B2%A1%E7%B6%93%E5%BF%AB%E8%A8%8A/990624/%E8%97%A5%E6%98%8E%E5%BA%B7%E5%BE%B7%E5%8F%8A%E8%97%A5%E6%98%8E%E7%94%9F%E7%89%A9%E5%86%8D%E6%BE%84%E6%B8%85-%E7%A8%B1%E4%B8%8D%E6%9C%83%E5%B0%8D%E7%BE%8E%E5%9C%8B%E6%A7%8B%E6%88%90%E5%9C%8B%E5%AE%B6%E5%AE%89%E5%85%A8%E9%A2%A8%E9%9A%AA\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://cdn.hk01.com/di/media/images/dw/20220310/578513246076538880087962.png/-bOyz0eXCE3Kd8ClV-mm1zJ2zupVfwS3jyFVr48hVa8","relate_stocks":{"603259":"药明康德","BK1610":"ETF&股票定投概念","LU0181495838.USD":"施罗德新兴亚洲A Acc","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","BK1521":"挪威政府全球养老基金持仓","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","BK0216":"研究试验","LU0823426480.USD":"法巴中国股票经典Dis","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","LU0359201612.USD":"贝莱德中国基金A2","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU1997245177.USD":"安联神洲A股基金","BK1576":"医药外包概念","LU1046422090.SGD":"Fidelity Pacific A-SGD","LU0140636845.USD":"施罗德大中华区股票A Acc","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","BK1589":"北水核心资产","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU0856984785.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"ACH\" (SGDHDG) ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU1242518857.USD":"FULLERTON LUX FUNDS - ASIA ABSOLUTE ALPHA \"I\" (USD) ACC","SG9999002562.SGD":"LionGlobal Asia Pacific SGD","BK1583":"高瓴概念","02359":"药明康德","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU0819121731.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"AC\" (USD) ACC","LU1720050803.USD":"安联全方位中国股票基金","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","LU1688375341.USD":"贝莱德中国灵活股票基金","02269":"药明生物","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU0823426308.USD":"法巴中国股票基金","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","LU1242518931.SGD":"Fullerton Lux Funds - Asia Absolute Alpha A Acc SGD","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD"},"source_url":"https://www.hk01.com/%E8%B2%A1%E7%B6%93%E5%BF%AB%E8%A8%8A/990624/%E8%97%A5%E6%98%8E%E5%BA%B7%E5%BE%B7%E5%8F%8A%E8%97%A5%E6%98%8E%E7%94%9F%E7%89%A9%E5%86%8D%E6%BE%84%E6%B8%85-%E7%A8%B1%E4%B8%8D%E6%9C%83%E5%B0%8D%E7%BE%8E%E5%9C%8B%E6%A7%8B%E6%88%90%E5%9C%8B%E5%AE%B6%E5%AE%89%E5%85%A8%E9%A2%A8%E9%9A%AA","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2411317328","content_text":"药明系再次发出澄清公告。药明康德（2359）重申没有人类基因组学业务，现有各类业务不会收集人类基因组数据。同时指出提供基于合同的研究、开发和生产服务，通过赋能全球制药和生命科学行业，致力于推动新药研发并为患者带来挽救生命的新药。公司亦指出注意到，有美国议员于2024年2月12日致函美国商务部、财政部和国防部，其内容有关本公司。公司表示一向欢迎监管机构对行业监管，过去亦多次成功通过美国政府的审查。但是强烈反对针对公司的误导性指称、不确实认定和未经正当程序的预判行动。公司坚信在过去没有、现在和未来都不会对美国构成国家安全风险，即便美国政府再次对公司进行审查亦将得出相同结论。事实上，药明康德是全球制药和生命科学行业的重要贡献者之一。药明生物强调自己属独立公司至于同系的药明生物（2269）亦发出公告，指出注意到有美国”议员于2月12日致函美国部分政府部门，其中提到公司。公司澄清并非药明康德新药，信函中的相关陈述失实，又强调公司是一家在香港联合交易所有限公司主板上市的独立公众公司，并独立运营其业务。药明生物指出完全支持监管机构对行业监管，但强烈反对任何在未经正当考虑事实的情况下针该公司的不正确的陈述和缺乏根据的指控。公司谨此重申其过去没有、现在或未来也不会对美国或其他国家的国家安全构成风险，始终并将一贯遵守合规经营的原则，并遵照开展业务地区适用的法律法规运营。公司将一如既往地致力为全球医疗健康服务并作出贡献。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1453,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":25,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/273778850001024"}